Combined Effect of Sensory-motor Integration in Individuals With Postmenopausal Polyneuropathy (EMG)
The Combination Effect of Sensory-motor Integration in Postmenopausal Polyneuropathy: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mohamed AM Abo El Ros
- Phone Number: 01206530584
- Email: mohamed.aboelros@pt.ninu.edu.eg
Study Contact Backup
- Name: Mohamed AM Abo El Ros
- Phone Number: 01206530584
- Email: aboelroosmohamed61@gmail.com
Study Locations
-
-
-
Ismailia, Egypt, 8332601
- Recruiting
- Mohamed
-
Contact:
- Mohamed AM Abo El Ros, Ph.D
- Phone Number: 01206530584
- Email: mohamed.aboelros@pt.ninu.edu.eg
-
Contact:
-
Principal Investigator:
- Mohamed AM Abo El Ros, Ph.D
-
-
-
-
-
Amman, Jordan
- Recruiting
- Zaytona University in Jordon
-
Contact:
- Mohamed M Abo-El-Ros, Ph.D
- Phone Number: A 00960781524278
- Email: 3767@zuj.edu.jo
-
Contact:
- Kerolous I Kelini, Ph.D
- Phone Number: S 00201229712126
- Email: 3530@zuj.edu.jo
-
Principal Investigator:
- Mohamed M Abo-El-Ros, Ph.D
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- polyneuropathy pos-tmaneuposal
- Type II Diabetes Mellitus
- Suffering from numbness in upper and lower limbs for more than 4 months
Exclusion Criteria:
- hysterectomy
- tumors
- antidepressant dugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group A
has received Sensory Motor Integration was given in the form of tactile stimulation, thermal stimulation and proprioceptive stimulation as well as motor integration was given in the form of strengthening exercises and pelvic rocking training for 6 weeks
|
pelvic rocking training and strengthening exercises
Other Names:
|
|
Active Comparator: Broup B
will recieve conventional exercises in the form of Free exercises and gymnasium exercises of Upper limb and Lower limb along with 20 minutes walking
|
conventional
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain intensity
Time Frame: 6 weeks
|
pain management will be evaluated by visual analogue scale with a minimum score of zero, and the maximum score is ten in addition, zero means a better score
|
6 weeks
|
|
balance assessment
Time Frame: 6 weeks
|
changes in balance parameters will be evaluated by the Biodex balance system that calculate the mediolateral stability index, anteroposterior stability index, and the overall.
stability index.These indexes represent fluctuations around a zero point established before testing when the platform is stable.
A high oSi score indicates poor balance, and the patient's maximum overall score would be 1.60.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Kerlos Kellini, Ph.D, Al Zaytona University in Jordon
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB # 5/1/2025-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.